Economic Analysis of Low Volume Interventions Using Real-World Data: Costs of HIV Self-Testing Distribution and HIV Testing Services in West Africa From the ATLAS Project

Métogara Mohamed Traore, Kéba Badiane, Anthony Vautier, Arlette Simo Fotso (), Odé Kanku Kabemba, Nicolas Rouveau, Mathieu Maheu-Giroux, Marie-Claude Boily, Joseph Larmarange (), Fern Terris-Prestholt and Marc d'Elbée
Additional contact information
Métogara Mohamed Traore: SOLTHIS - Solidarité thérapeutique & initiatives contre le sida
Kéba Badiane: SOLTHIS - Solidarité thérapeutique & initiatives contre le sida
Anthony Vautier: SOLTHIS - Solidarité thérapeutique & initiatives contre le sida
Arlette Simo Fotso: CEPED - UMR_D 196 - Centre population et développement - IRD - Institut de Recherche pour le Développement - UPCité - Université Paris Cité, INED - Institut national d'études démographiques, SAGESUD - ERL Inserm U1244 - Santé, vulnérabilités et relations de genre au sud - INSERM - Institut National de la Santé et de la Recherche Médicale - CEPED - UMR_D 196 - Centre population et développement - IRD - Institut de Recherche pour le Développement - UPCité - Université Paris Cité
Odé Kanku Kabemba: SOLTHIS - Solidarité thérapeutique & initiatives contre le sida
Nicolas Rouveau: CEPED - UMR_D 196 - Centre population et développement - IRD - Institut de Recherche pour le Développement - UPCité - Université Paris Cité, SAGESUD - ERL Inserm U1244 - Santé, vulnérabilités et relations de genre au sud - INSERM - Institut National de la Santé et de la Recherche Médicale - CEPED - UMR_D 196 - Centre population et développement - IRD - Institut de Recherche pour le Développement - UPCité - Université Paris Cité
Mathieu Maheu-Giroux: McGill University = Université McGill [Montréal, Canada]
Marie-Claude Boily: Imperial College London
Joseph Larmarange: CEPED - UMR_D 196 - Centre population et développement - IRD - Institut de Recherche pour le Développement - UPCité - Université Paris Cité, SAGESUD - ERL Inserm U1244 - Santé, vulnérabilités et relations de genre au sud - INSERM - Institut National de la Santé et de la Recherche Médicale - CEPED - UMR_D 196 - Centre population et développement - IRD - Institut de Recherche pour le Développement - UPCité - Université Paris Cité
Fern Terris-Prestholt: LSHTM - London School of Hygiene and Tropical Medicine
Marc d'Elbée: BPH - Bordeaux population health - UB - Université de Bordeaux - Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED) - INSERM - Institut National de la Santé et de la Recherche Médicale, GHiGS - Global Health in the Global South - IRD - Institut de Recherche pour le Développement - BPH - Bordeaux population health - UB - Université de Bordeaux - Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED) - INSERM - Institut National de la Santé et de la Recherche Médicale

Post-Print from HAL

Abstract: Achieving the first 95 of the UNAIDS targets requires the implementation of innovative approaches to knowing one's HIV status. Among these innovations is the provision of HIV self-testing (HIVST) kits in west Africa by the international partner organization Solthis (IPO). In order to provide guidance for the optimal use of financial resources, this study aims to estimate the program and site level costs of dispensing HIVST as well as HIV testing services (HTS)-excluding HIVST-in health facilities in Côte d'Ivoire, Mali and Senegal as part of the ATLAS project. We estimated from the provider's perspective, HIVST and HTS incremental costs using top-down and bottom-up costing approaches and conducted a time and motion study. We identified costs at the program level for HIVST (including IPO central costs) and at the site level for HIVST and HTS. The economic costs of distributing HIVST kits were assessed in 37 health facilities between July 2019 and March 2021 (21 months). Sensitivity analyses were also performed on unit costs to examine the robustness of our estimates related to key assumptions. In total, 16,001 HIVST kits were dispensed for 32,194 HTS sessions carried out. Program level HIVST average costs ranged $12–286, whereas site level costs ranged $4–26 across distribution channels and countries. Site level HTS costs ranged $7–8 per testing session, and ranged $72–705 per HIV diagnosis. Across countries and channels, HIVST costs were driven by personnel (27–68%) and HIVST kits (32–73%) costs. The drivers of HTS costs were personnel costs ranging between 65 and 71% of total costs across distribution channels and countries, followed by supplies costs between 21 and 30%. While program level HIVST average costs were high, site level HIVST average costs remained comparable to HTS costs in all countries. Health facility-based distribution channels operating at low volume exhibit high proportion of central costs which should be considered carefully for financial planning when run alongside high volumes mobile outreach distribution channels. HIVST can diversify the HIV testing offer at health facilities, thus improving access to screening for target populations not reached by HTS services.

Keywords: real-world data; HIV self-testing; HIV testing services; health facilities; cost analysis; Côte d'Ivoire; Mali; Senegal; West Africa (search for similar items in EconPapers)
Date: 2022-06-27
Note: View the original document on HAL open archive server: https://hal.science/hal-03823352v1
References: View complete reference list from CitEc
Citations:

Published in Frontiers in Health Services, 2022, 2 (886513), pp.1-11. ⟨10.3389/frhs.2022.886513⟩

Downloads: (external link)
https://hal.science/hal-03823352v1/document (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-03823352

DOI: 10.3389/frhs.2022.886513

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().